Cobimetinib
ATC L01EE02 · 8 markets · 11 records
AU 3 records · 3 strengths
- 20 mgtabletCotellic
- 22.2 mgtabletCOTELLIC cobimetinib 20 mg film-coated tablet blister pack
Records without a stated strength · 1 Cotellic
US 1 records · 1 strengths
- 20 mgtabletCotellic
GB 1 records · 1 strengths
- 20 mgtabletCotellic
CA 1 records · 1 strengths
- 20 mgtabletCotellic
SG 1 records · 1 strengths
- 20 mgtabletCotellic
ES 1 records · 1 strengths
- 20 mgtabletCotellic
TW 1 records · 1 strengths
- 20 mgtabletCotellic可泰利 膜衣錠20毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Cotellic
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | EU |
|---|---|---|---|---|---|---|---|---|
| 20 mg tablet | Cotellic | Cotellic | Cotellic | Cotellic | Cotellic | Cotellic | Cotellic 可泰利 膜衣錠20毫克 | |
| 22.2 mg tablet | COTELLIC cobimetinib 20 mg film-coated tablet blister pack | |||||||
unknown | Cotellic | Cotellic |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.